PetVivo HoldingsPETVW 35 Net Margin % is -766.08% as of Dec. 2025. GuruFocus rates PETVW with a GF Score™ of 35/100. The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 93.02% on this metric.
The historical rank and industry rank for PetVivo Holdings's Net Margin % or its related term are showing as below:
PETVW'
s Net Margin % Range Over the Past 10 Years
Min: -221885.71 Med: -4869.33 Max: -741.31
Current: -892.99
PETVW's Net Margin % is ranked worse than 93.02% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs PETVW: -892.99
PetVivo Holdings (OTCPK:PETVW) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PetVivo Holdings Net Margin % Related Terms
PetVivo Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for PetVivo Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETVW vs MODD, NMTC, CTSO: Net Margin % Comparison
For the Medical Devices subindustry, PetVivo Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (PETVW) has a Net Margin % of -766.08% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on PetVivo Holdings and its competitors. According to the industry distribution chart, PetVivo Holdings ranks #760 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 93%.
Is PetVivo Holdings' Net Margin % too high?
PetVivo Holdings' current Net Margin % is -766.08%. Based on the distribution chart, PetVivo Holdings ranks #760 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Net Margin % compare to MODD and NMTC?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #760 out of 817 companies for Net Margin %. This places PetVivo Holdings in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current Net Margin % is -766.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
PetVivo Holdings (PETVW) has a current Net Margin % of -766.08%. The current Net Margin % is -766.08%. PetVivo Holdings' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PetVivo Holdings (PETVW), the current Net Margin % is -766.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
35GF Score
Get the complete analysis for PETVW
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETVW has been successfully added to your 
